Clinical Trial Results: Long-Term Study (AtDvance) to Evaluate GSK1070806 in Atopic Dermatitis. [Phase 2]

View source ↗

Summary

Phase 2 long-term study of GSK1070806 in atopic dermatitis has been terminated with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atopic Dermatitis
• Dermatitis

Drugs mentioned

• GSK1070806

Snippet

Sponsor: GlaxoSmithKline | Conditions: Dermatitis, Atopic | Phase 2 | Status: TERMINATED | Results posted: 2026-06-16